poliovirus

An investigational therapy using modified poliovirus to attack cancer tumors appears to unleash the body’s own capacity to fight malignancies by activ...

The V Foundation for Cancer Research has awarded David Ashley, MBBS, FRACP, PhD, a three-year $600,000 grant for his proposed research project “Poliov...

The recombinant poliovirus therapy developed at the Preston Robert Tisch Brain Tumor Center at Duke Health has been granted “breakthrough therapy desi...

A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurre...

On Wednesday, Sept. 28, Matthias Gromeier, MD; Eric Thompson, MD; and Darell Bigner, MD, PhD; received a check for $208,408 from The Andrew McDonough ...